Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Find US Patent Information with US Patent Number, Application Number and Patent Expiration Date of Efavirenz on PharmaCompass.com

    Client Email Product

    Efavirenz

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    PRICE INFORMATION

    INTERMEDIATES

    DOSSIERs // Finished Dosage Formulations

    DRUG PRODUCT COMPOSITION

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS

    ANALYTICAL SOLUTION(s)

    DIGITAL CONTENT

    PharmaCompass
    Related ProductsRelated Products
    API SUPPLIERS
    API Suppliers

    API Suppliers

    41
    US DMFs Filed

    US DMFs Filed

    28
    CEP/COS Certifications

    CEP/COS Certifications

    0

    JDMFs Filed

    JDMFs Filed

    0

    Other Certificates

    Other Certificates

    12
    Other Suppliers

    Other Suppliers

    20
    API REF. PRICE (USD / KG)
    95

    API Market Place

    8
    INTERMEDIATES
    5
    DOSSIERS // FDF
    USA (Orange Book)

    USA (Orange Book)

    58
    Europe

    Europe

    40
    Canada

    Canada

    11
    Australia

    Australia

    2
    South Africa

    South Africa

    60
    Uploaded Dossiers

    Uploaded Dossiers

    19
    GLOBAL SALES (USD Million)

    U.S. Medicaid

    1,123.00

    Annual Reports

    1,489.00

    FDF Market Place

    5
    EXCIPIENTS
    180
    PATENTS & EXCLUSIVITIES

    USFDA Orange Book Patents

    10

    USFDA Exclusivities

    0

    DIGITAL CONTENT

    Blog #PharmaFlow

    3

    News

    55
    REF STANDARD

    EDQM

    0

    USP

    5

    JP

    0

    Other Listed Suppliers

    5
    SERVICES
    1
    left grey arrow
    right gray arrow
    • TABLET;ORAL - 400MG;300MG;300MG
    • CAPSULE;ORAL - 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
    • CAPSULE;ORAL - 200MG
    • CAPSULE;ORAL - 50MG
    • TABLET;ORAL - 300MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
    • TABLET;ORAL - 600MG
    • TABLET;ORAL - 600MG;200MG;300MG
    left grey arrow
    right gray arrow
    Full View ScreenFull Screen View
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info

    GILEAD SCIENCES

    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE

    PDF Supplier PDF
    URL Supplier Web Content
    8592397
    Y
    2024-01-13
    U-750
    21937
    TREATMENT OF HIV-1 INFECTION IN ADULTS
    1
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    GILEAD SCIENCES

    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE

    PDF Supplier PDF
    URL Supplier Web Content
    9018192
    2026-06-13
    U-1170
    21937
    TREATMENT OF HIV-1 INFECTION IN PEDIATRIC PATIENTS 12 YEARS OF AGE AND OLDER
    1
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    GILEAD SCIENCES

    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE

    PDF Supplier PDF
    URL Supplier Web Content
    8598185
    Y
    2029-04-28
    21937
    1
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    GILEAD SCIENCES

    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE

    PDF Supplier PDF
    URL Supplier Web Content
    9457036
    Y
    2024-01-13
    U-257
    21937
    TREATMENT OF HIV INFECTION
    1
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    GILEAD SCIENCES

    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE

    PDF Supplier PDF
    URL Supplier Web Content
    9545414
    Y
    2026-06-13
    U-750
    21937
    TREATMENT OF HIV-1 INFECTION IN ADULTS
    1
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    GILEAD SCIENCES

    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE

    PDF Supplier PDF
    URL Supplier Web Content
    9545414
    Y
    2026-06-13
    U-1170
    21937
    TREATMENT OF HIV-1 INFECTION IN PEDIATRIC PATIENTS 12 YEARS OF AGE AND OLDER
    1
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    GILEAD SCIENCES

    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE

    PDF Supplier PDF
    URL Supplier Web Content
    9744181
    Y
    2024-01-13
    U-257
    21937
    TREATMENT OF HIV INFECTION
    1
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    GILEAD SCIENCES

    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE

    PDF Supplier PDF
    URL Supplier Web Content
    9018192
    2026-06-13
    U-750
    21937
    TREATMENT OF HIV-1 INFECTION IN ADULTS
    1
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    GILEAD SCIENCES

    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE

    PDF Supplier PDF
    URL Supplier Web Content
    8716264
    Y
    2024-01-13
    U-257
    21937
    TREATMENT OF HIV INFECTION
    1
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    GILEAD SCIENCES

    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE

    PDF Supplier PDF
    URL Supplier Web Content
    8592397
    Y
    2024-01-13
    U-1170
    21937
    TREATMENT OF HIV-1 INFECTION IN PEDIATRIC PATIENTS 12 YEARS OF AGE AND OLDER
    1
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    veranova-m-2024-04-22

    Access Virtual Booth

    Contact Supplier

    View Presentation

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Access Virtual Booth

    Contact Supplier

    View Presentation

    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search